🔎 Trials Near Me

Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Pennsylvania › Philadelphia

Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Philadelphia, PA

5 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

RecruitingPhase 2
  • Site Number - 1616, Philadelphia
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07032662

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

RecruitingPhase 3
  • Penn Medicine University City, Philadelphia
  • Jefferson Health Honickman Center, Philadelphia
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07091630

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

RecruitingPhase 3
  • Perelman Center for Advanced Medicine, Philadelphia
  • Jefferson Health Honickman Center, Philadelphia
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06920004

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

RecruitingPhase 3
  • Penn Medicine: University of Pennsylvania Health System- Site Number : 8400022, Philadelphia
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06290141

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

RecruitingPhase 2
  • Penn Blood Disorders Program - Hospital of The University of Pennsylvania, Philadelphia
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT06798012

Chronic Inflammatory Demyelinating Polyradiculoneuropathy trials in other cities

Other studies in Philadelphia

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.